Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Innate Pharma | IDD | Apr 17, 2025 | 1.73 | +1.53 |
Innate Pharma S.A. - American Depositary Shares | IDDA | Apr 17, 2025 | 1.65 | -1.20 |
Innelec Multimedia | 1W2 | Apr 17, 2025 | 2.67 | -5.15 |
Innergex Renewable Energy Inc | 3IX | Apr 17, 2025 | 8.51 | -0.14 |
InnoCan Pharma Corp | IP4 | Apr 17, 2025 | 0.11 | +0.95 |
Innodata Inc. | ID6 | Apr 17, 2025 | 31.30 | +2.15 |
Innofactor | TJG | Apr 17, 2025 | 1.68 | 0.00 |
Innospec Inc. | OCT | Apr 17, 2025 | 75.00 | -2.60 |
Innotec TSS AG | TSS | Apr 17, 2025 | 7.10 | +4.41 |
Innovate | PST0 | Apr 17, 2025 | 5.15 | 0.00 |
Innovatec S.p.A. | 5JT | Apr 17, 2025 | 0.17 | +6.75 |
Innovative Industrial Properties, Inc. | 1IK | Apr 17, 2025 | 44.76 | +2.05 |
Innovent Biologics Inc | 6IB | Apr 17, 2025 | 5.25 | -2.78 |
Innovex International | DQU0 | Apr 17, 2025 | 13.90 | +4.51 |
Innoviva, Inc. | HVE | Apr 17, 2025 | 16.00 | 0.00 |
Inogen, Inc | 6IO | Apr 17, 2025 | 6.05 | -4.72 |
Inomin Mines Inc | IMC | Apr 17, 2025 | 0.01 | -11.11 |
Inotiv, Inc. | BS50 | Apr 17, 2025 | 1.40 | -7.28 |
Inovio Pharmaceuticals | GBM | Apr 17, 2025 | 1.53 | -4.38 |
Inpex Corporation | I8U | Apr 17, 2025 | 10.89 | +0.55 |
InPlay Oil Corp | 8DA1 | Apr 17, 2025 | 0.76 | 0.00 |
Inpost S.A | 6690 | Apr 17, 2025 | 6.60 | +5.60 |
Inpost S.A | 669 | Apr 17, 2025 | 14.00 | +5.74 |
Inseego | INO0 | Apr 17, 2025 | 6.05 | -5.47 |
Insig AI Plc | 8LF | Apr 17, 2025 | 0.17 | +4.32 |
Insight Enterprises, Inc. | IEI | Apr 17, 2025 | 117.05 | -0.97 |
INSIGNIA FINANCIAL LTD. | IOH | Apr 17, 2025 | 2.06 | +4.57 |
Insmed, Inc. | IM8N | Apr 17, 2025 | 61.50 | -1.60 |
Inspecs Group Plc | 4GV | Apr 17, 2025 | 0.38 | -2.55 |
Insperity Inc | ASF | Apr 17, 2025 | 70.00 | -3.45 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.